Article
Mutant IL-2-expressing mesenchymal stromal cells promote regulatory T cells proliferation and activation in collagen induced arthritis mice.
Arthritis research & therapy - 8 Dec 2025
Tang Zhicheng, Yang Fan, Shen Jingyi, Wu Haolin, Hong Huiming, Wang Yue, Yin Fanzhang, Tang Xiaojun, Zhang Huayong
Abstract excerpt
OBJECTIVES: Research indicates that low doses of interleukin-2 (IL-2) can effectively mitigate Rheumatoid arthritis (RA) symptoms by promoting Treg cells, while high doses may enhance immune responses and exacerbate the disease. Consequently, this study employed mutated IL-2 to minimize its impact on CD8+ T and NK cell activation while preserving its influence on Treg cells. METHODS: We used a previously...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
